Show simple item record

dc.contributor.authorCornistein, Wanda.
dc.contributor.authorGarcía, Juan.
dc.contributor.authorAppel, Tobias.
dc.contributor.authorEt al.
dc.identifier.citationExpert Rev Anti Infect Ther . 2021 Feb;19(2)
dc.descriptionDisponible en:
dc.description.abstractAbstract Introduction: Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam antibiotics, including carbapenems. Carbapenemase production in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., with and without the co-expression of other β-lactamases is a serious public health threat. Carbapenemases belong to three main classes according to the Ambler classification: class A, class B, and class D. Areas covered: Carbapenemase-bearing pathogens are endemic in Latin America. In this review, we update the status of carbapenemases in Latin America and the Caribbean. Expert opinion: Understanding the current epidemiology of carbapenemases in Latin America and the Caribbean is of critical importance to improve infection control policies limiting the dissemination of multi-drug-resistant pathogens and in implementing appropriate antimicrobial therapy. Keywords: Acinetobacter baumannii; Klebsiella pneumoniae; Pseudomonas aeruginosa; Latin America; carbapenem resistance; carbapenem-resistant Enterobacterales (CRE); carbapenemases;
dc.publisherTaylor and Francis Groupes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.subjectAcinetobacter baumanniies
dc.subjectKlebsiella pneumoniaees
dc.subjectPseudomonas aeruginosaes
dc.titleUpdate on the epidemiology of carbapenemases in Latin America and the Caribbeanes

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional